Insider trading

Period: 120 months Stock: NTLA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

152 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

152 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

152 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

152 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
152 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
152 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

152 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
31 Oct 2023
Bhanji Muna Director
Sold on a plan
$6.33K 265 at 23.90
2.2%
Planned (10b5-1)
31 Jul 2023
Bhanji Muna Director
Sold on a plan
$11.22K 265 at 42.33
2.1%
Planned (10b5-1)
6 Jul 2023
Bhanji Muna Director
Sold on a plan
$73.37K 1,867 at 39.30
13.0%
Planned (10b5-1)
3 Jul 2023
Clark Eliana EVP, Chief Technical Officer
Sold at will
$14.58K 360 at 40.51
0.8%
Not planned
20 Jun 2023
Clark Eliana EVP, Chief Technical Officer
Sold on a plan
$225.00K 5,000 at 45.00
10.0%
Planned (10b5-1)
2 Mar 2023
BASTA JAMES EVP, General Counsel
Sold, plan not stated
$47.74K 1,088 at 43.88
1.9%
5 Jan 2023
Sepp-Lorenzino Laura EVP, Chief Scientific Officer
Sold, plan not stated 2×
$89.66K 2,330 at 38.48
11.7%
4 Jan 2023
LEONARD JOHN M President and CEO
Sold, plan not stated
$248.30K 6,673 at 37.21
0.9%
4 Jan 2023
Lebwohl David EVP, Chief Medical Officer
Sold, plan not stated
$95.78K 2,574 at 37.21
9.1%
4 Jan 2023
Sepp-Lorenzino Laura EVP, Chief Scientific Officer
Sold, plan not stated
$93.32K 2,508 at 37.21
11.2%
4 Jan 2023
Goddard Glenn EVP, Chief Financial Officer
Sold, plan not stated
$90.31K 2,427 at 37.21
13.6%
4 Jan 2023
Hicks Derek EVP, Chief Business Officer
Sold, plan not stated
$67.42K 1,812 at 37.21
9.5%
4 Jan 2023
Clark Eliana EVP, Chief Technical Officer
Sold, plan not stated
$62.96K 1,692 at 37.21
10.5%
4 Jan 2023
BASTA JAMES EVP, General Counsel
Sold, plan not stated
$42.34K 1,138 at 37.21
5.5%
3 Jan 2023
Clark Eliana EVP, Chief Technical Officer
Sold, plan not stated
$7.96K 231 at 34.48
1.4%
1 Jul 2022
Clark Eliana EVP, Chief Technical Officer
Sold, plan not stated
$5.43K 105 at 51.74
0.6%
1 Jan 2022
LEONARD JOHN M President and CEO
Sold, plan not stated
$279.85K 2,493 at 112.26
0.3%
1 Jan 2022
Sepp-Lorenzino Laura EVP, Chief Scientific Officer
Sold, plan not stated
$128.86K 1,148 at 112.25
19.3%
1 Jan 2022
Lebwohl David EVP, Chief Medical Officer
Sold, plan not stated
$117.96K 1,051 at 112.24
8.8%
1 Jan 2022
Goddard Glenn EVP, Chief Financial Officer
Sold, plan not stated
$113.70K 1,013 at 112.24
33.1%
5 Nov 2021
Lebwohl David EVP, Chief Medical Officer
Sold, plan not stated 4×
$318.53K 2,400 at 132.72
21.6%
14 Oct 2021
Lebwohl David EVP, Chief Medical Officer
Sold, plan not stated 5×
$308.25K 2,400 at 128.44
21.6%
11 Oct 2021
Crowley John F Director
Sold, plan not stated
$298.88K 2,500 at 119.55
54.4%
Sold half or more
5 Oct 2021
Crowley John F Director
Sold, plan not stated 5×
$1.31M 10,000 at 130.54
82.7%
Sold half or more
21 Sep 2021
Lebwohl David EVP, Chief Medical Officer
Sold, plan not stated
$359.54K 2,400 at 149.81
75.2%
Sold half or more
7 Sep 2021
Goddard Glenn EVP, Chief Financial Officer
Sold, plan not stated
$627.18K 3,482 at 180.12
100%
Sold half or more
1 Sep 2021
LEONARD JOHN M President and CEO
Sold, plan not stated
$7.60M 44,735 at 170.00
5.9%
31 Aug 2021
LEONARD JOHN M President and CEO
Sold, plan not stated
$5.86M 37,833 at 155.00
5.0%
31 Aug 2021
Goddard Glenn EVP, Chief Financial Officer
Sold, plan not stated
$3.97M 24,800 at 160.22
100%
Sold half or more
30 Aug 2021
Sepp-Lorenzino Laura EVP, Chief Scientific Officer
Sold, plan not stated 9×
$15.02M 97,000 at 154.83
97.6%
Sold half or more
30 Aug 2021
LEONARD JOHN M President and CEO
Sold, plan not stated 9×
$6.05M 38,804 at 155.95
5.1%
30 Aug 2021
Goddard Glenn EVP, Chief Financial Officer
Sold, plan not stated 8×
$810.08K 5,200 at 155.78
100%
Sold half or more
30 Aug 2021
Lebwohl David EVP, Chief Medical Officer
Sold, plan not stated 5×
$379.30K 2,400 at 158.04
75.2%
Sold half or more
23 Aug 2021
LEONARD JOHN M President and CEO
Sold, plan not stated 3×
$4.13M 27,139 at 152.01
3.6%
19 Aug 2021
LEONARD JOHN M President and CEO
Sold, plan not stated 3×
$3.43M 22,682 at 151.28
3.1%
9 Aug 2021
Lebwohl David EVP, Chief Medical Officer
Sold, plan not stated
$393.72K 2,400 at 164.05
75.2%
Sold half or more
5 Aug 2021
Goddard Glenn EVP, Chief Financial Officer
Sold, plan not stated 3×
$3.02M 20,000 at 151.05
100%
Sold half or more
4 Aug 2021
Sepp-Lorenzino Laura EVP, Chief Scientific Officer
Sold, plan not stated 7×
$3.59M 26,000 at 138.24
91.6%
Sold half or more
28 Jun 2021
FORMELA JEAN FRANCOIS Director · indirect
Sold, plan not stated 18×
$73.45M 553,376 at 132.73
98.2%
Sold half or more
14 Jun 2021
FORMELA JEAN FRANCOIS Director · indirect
Sold, plan not stated 4×
$14.86M 170,126 at 87.36
23.2%
14 Jun 2021
FORMELA JEAN FRANCOIS Director · indirect
Sold, plan not stated
$58.28K 653 at 89.25
0.1%
11 Jun 2021
FORMELA JEAN FRANCOIS Director · indirect
Sold, plan not stated 2×
$2.64M 30,946 at 85.23
4.0%
29 Apr 2021
FORMELA JEAN FRANCOIS Director · indirect
Sold, plan not stated
$385.55K 4,513 at 85.43
0.6%
28 Apr 2021
FORMELA JEAN FRANCOIS Director · indirect
Sold, plan not stated 2×
$11.29M 131,926 at 85.56
14.6%
27 Apr 2021
FORMELA JEAN FRANCOIS Director · indirect
Sold, plan not stated 3×
$18.13M 210,230 at 86.22
18.9%
26 Apr 2021
FORMELA JEAN FRANCOIS Director · indirect
Sold, plan not stated
$68.45K 806 at 84.93
0.1%
5 Apr 2021
DORSA CAROLINE Director
Sold, plan not stated 3×
$616.40K 7,500 at 82.19
58.1%
Sold half or more
5 Apr 2021
FORMELA JEAN FRANCOIS Director · indirect
Sold, plan not stated
$67.98K 800 at 84.98
0.1%
1 Apr 2021
Rivera Jose E EVP, General Counsel
Sold, plan not stated 21×
$4.16M 50,455 at 82.46
27.8%
1 Apr 2021
LEONARD JOHN M President and CEO
Sold, plan not stated 2×
$3.20M 38,209 at 83.64
5.3%
Showing 51–100 of 152. ← Newer Page 2 of 4 Older →